Delivra Health Brands Stock Today
| DHBUF Stock | USD 0.01 0 10.24% |
Performance0 of 100
| Odds Of DistressOver 61
|
Delivra Health is trading at 0.014 as of the 23rd of November 2024. This is a 10.24 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0105. Delivra Health has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Delivra Health Brands are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of September 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada. Delivra Health is traded on OTC Exchange in the United States.. The company has 252.62 M outstanding shares. More on Delivra Health Brands
Moving together with Delivra OTC Stock
Moving against Delivra OTC Stock
Delivra OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Delivra Health Brands [DHBUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.71 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Delivra Health's market, we take the total number of its shares issued and multiply it by Delivra Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Delivra Health Brands classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 252.62 M outstanding shares.
Delivra Health Brands has accumulated about 1.67 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Delivra Health Probability Of Bankruptcy
Ownership AllocationDelivra Health holds a total of 252.62 Million outstanding shares. Delivra Health Brands retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Delivra Ownership Details
Delivra Health Brands Risk Profiles
| Mean Deviation | 6.98 | |||
| Semi Deviation | 8.5 | |||
| Standard Deviation | 10.58 | |||
| Variance | 111.93 |
Delivra Stock Against Markets
Picking the right benchmark for Delivra Health otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Delivra Health otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Delivra Health is critical whether you are bullish or bearish towards Delivra Health Brands at a given time. Please also check how Delivra Health's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Delivra Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Delivra Health Corporate Management
Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gord Davey | CEO Pres | Profile | |
| Ann Gallery | Sr Communications | Profile | |
| CPA CMA | CFO Sec | Profile | |
| Matthew Wagar | VP Innovation | Profile | |
| Will Stewart | Sr Affairs | Profile | |
| CPA CGA | VP Fin | Profile | |
| Jonathan Hartshorn | Pres Satipharm | Profile |
Other Information on Investing in Delivra OTC Stock
Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.